Results of the AIDA STEMI MRI sub-study presented at TCT 2012

Study confirms that intracoronary and intravenous use of abciximab during angioplasty yield similar results

2012-10-26

(Press-News.org) MIAMI, FL – OCTOBER 25, 2012 – A study confirmed no differences in various measures of heart damage, according to cardiac magnetic resonance (MRI) imaging, in patients receiving the anti-clotting medication abxicimab directly into the heart (intracoronary) compared to those receiving it intravenously (IV). The results of the AIDA STEMI MRI sub-study were presented today the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

The AIDA STEMI trial was a randomized, open-label, multicenter trial in 2,065 patients presenting with ST-elevation myocardial infarction (STEMI) comparing intracoronary (IC) versus intravenous (IV) abciximab during PCI with subsequent 12 hour intravenous infusion. Last year, researchers reported that the trial found that both methods yielded similar 90-day rates of all-cause mortality, recurrent heart attack or congestive heart failure.

Researchers enrolled 703 patients within the overall trial in a cardiac magnetic resonance imaging sub-study, one of the largest MRI sub-studies conducted in patients with STEMI. Cardiac MRI allows for a more sensitive investigation of the mechanistic and pathophysiological effects of STEMI therapies on myocardial damage and reperfusion injury.

Cardiac MRI was completed within four days after heart attack using a standardized protocol including edema imaging and late gadolinium enhancement. Researchers examined infarct size, myocardial salvage, microvascular obstruction and ventricular function to determine the potential benefits of intracoronary compared to intravenous application of abciximab.

The amount of myocardium at risk and final infarct size did not differ significantly between the IC versus the IV abciximab groups. Consequently, the myocardial salvage index was similar between the two groups. In further detailed analysis there were no differences in microvascular obstruction between both treatment groups.

"Results of this sub-study demonstrate that intracoronary as compared to intravenous abciximab did not result in a difference in myocardial damage or reperfusion injury," said lead investigator Holger Thiele, MD. Dr. Thiele is Co-Director of the University of Leipzig - Heart Center in Germany.

"These findings confirm similarities in the combined endpoint of death, reinfarction and congestive heart failure found between the two methods in the AIDA STEMI trial," Dr. Thiele said.

Dr. Thiele will present the AIDA STEMI MRI sub-study on Thursday October 25 at 12:30 PM EST in the Main Arena (Hall D) at the Miami Beach Convention Center.

### The trial was funded by Lilly Germany, the University of Leipzig - Heart Center and Clinical Trial Centre, and the Federal Ministry of Education and Research. Dr. Thiele reported research funding from Terumo, Lilly, Maquet Cardiovascular, and Teleflex Medical; consulting for Maquet Cardiovascular and Avidal; and speaker honoraria for Lilly, AstraZeneca, Daiichi Sankyo, Boehringer Ingelheim, Maquet Cardiovascular, and The Medicines Company.

About CRF The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of the Cardiovascular Research Foundation. TCT gathers leading medical researchers and clinicians from around the world to present and discuss the latest developments in the field.

For more information, visit www.crf.org. END

ELSE PRESS RELEASES FROM THIS DATE:

Report: Bushmeat pushes Southern African species to the brink

2012-10-26

JOHANNESBURG, SOUTH AFRICA (October 25, 2012) – A recent report says illegal hunting of wildlife in South African Development Community (SADC) states can lead to the eradication of many species across extensive areas and even complete ecological collapse. Africa's iconic large carnivores, such as cheetah, lion, leopard, and wild dog, are particularly vulnerable to this practice, either because they are caught in the bycatch from unselective methods such as snaring, or due to loss of prey. The report says that the scale and severity of the threat is such that, without ...

UC Davis researchers develop new drug delivery system for bladder cancer using nanoparticles

2012-10-26

(SACRAMENTO, Calif.) -- A team of UC Davis scientists has shown in experimental mouse models that a new drug delivery system allows for administration of three times the maximum tolerated dose of a standard drug therapy for advanced bladder cancer, leading to more effective cancer control without increasing toxicity. The delivery system consists of specially designed nanoparticles that home in on tumor cells while carrying the anti-cancer drug paclitaxel. The same delivery system also was successfully used to carry a dye that lights up on imaging studies, making it potentially ...

New genomics study shows ancestry could help solve disease riddles

2012-10-26

LA JOLLA, CA – October 25, 2012 – Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge. But now a new study by scientists at The Scripps Research Institute (TSRI), Scripps Health, and Scripps Translational Science Institute (STSI) reveals that by comparing the genomes of diseased patients with the genomes of ...

A 'nanoscale landscape' controls flow of surface electrons on a topological insulator

2012-10-26

CHESTNUT HILL, MA (October 25, 2012) – In the relatively new scientific frontier of topological insulators, theoretical and experimental physicists have been studying the surfaces of these unique materials for insights into the behavior of electrons that display some very un-electron-like properties. In topological insulators, electrons can behave more like photons, or particles of light. The hitch is that unlike photons, electrons have a mass that normally plays a defining role in their behavior. In the world of quantum physics, where everyday materials take on surprising ...

Changing the balance of bacteria in drinking water to benefit consumers

2012-10-26

WASHINGTON, Oct. 25, 2012 — The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series reports that scientists have discovered a plausible way to manipulate the populations of mostly beneficial microbes in "purified" drinking water to potentially benefit consumers. Based on a report by Lutgarde Raskin, Ph.D., in ACS' journal Environmental Science & Technology, the new podcast is available without charge at iTunes and from www.acs.org/globalchallenges. In the new episode, Raskin explains that municipal ...

Small marine organisms' big changes could affect world climate

2012-10-26

In the future, warmer waters could significantly change ocean distribution of populations of phytoplankton, tiny organisms that could have a major effect on climate change. Reporting in this week's online journal Science Express, researchers show that by the end of the 21st century, warmer oceans will cause populations of these marine microorganisms to thrive near the poles and shrink in equatorial waters. "In the tropical oceans, we are predicting a 40 percent drop in potential diversity, the number of strains of phytoplankton," says Mridul Thomas, a biologist at Michigan ...

Small organisms could dramatically impact world's climate

2012-10-26

EAST LANSING, Mich. — Warmer oceans in the future could significantly alter populations of phytoplankton, tiny organisms that could have a major impact on climate change. In the current issue of Science Express, Michigan State University researchers show that by the end of the 21st century, warmer oceans will cause populations of these marine microorganisms to thrive near the poles and may shrink in equatorial waters. Since phytoplankton play a key role in the food chain and the world's cycles of carbon, nitrogen, phosphorous and other elements, a drastic drop could have ...

Individual gene differences can be tested in zebrafish

2012-10-26

HERSHEY, Pa. -- The zebrafish is a potential tool for testing one class of unique individual genetic differences found in humans, and may yield information helpful for the emerging field of personalized medicine, according to a team led by Penn State College of Medicine scientists. The differences, or mutations, in question create minor changes in amino acids -- the building blocks of DNA -- from person to person. Zebrafish can be used as a model to understand what biological effects result from these genetic mutations. Personalized medicine uses modern technology and ...

Monster galaxy may have been stirred up by black-hole mischief

2012-10-26

Astronomers using the NASA/ESA Hubble Space Telescope have obtained a remarkable new view of a whopper of an elliptical galaxy, with a core bigger than any seen before. There are two intriguing explanations for the puffed up core, both related to the action of one or more black holes, and the researchers have not yet been able to determine which is correct. Spanning a little over one million light-years, the galaxy is about ten times the diameter of the Milky Way galaxy. The bloated galaxy is a member of an unusual class of galaxies with an unusually diffuse core filled ...

Exercise boosts satisfaction with life, researchers find

2012-10-26

UNIVERSITY PARK, Pa. -- Had a bad day? Extending your normal exercise routine by a few minutes may be the solution, according to Penn State researchers, who found that people's satisfaction with life was higher on days when they exercised more than usual. "We found that people's satisfaction with life was directly impacted by their daily physical activity," said Jaclyn Maher, graduate student in kinesiology. "The findings reinforce the idea that physical activity is a health behavior with important consequences for daily well-being and should be considered when developing ...

Results of the AIDA STEMI MRI sub-study presented at TCT 2012

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: